464 related articles for article (PubMed ID: 14719353)
1. Antifibrinolytics.
Schmarts
Acta Anaesthesiol Belg; 2003; 54(4):319-22. PubMed ID: 14719353
[No Abstract] [Full Text] [Related]
2. Antifibrinolytics in liver transplantation.
Groenland TH; Porte RJ
Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208
[No Abstract] [Full Text] [Related]
3. Current status of non-transfusional haemostatic agents.
Cattaneo M; Mannucci PM
Haematologica; 1999 Jun; 84 Suppl EHA-4():120-3. PubMed ID: 10907488
[No Abstract] [Full Text] [Related]
4. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
Hardy JF; Bélisle S
Can J Anaesth; 1997 Sep; 44(9):913-7. PubMed ID: 9305552
[No Abstract] [Full Text] [Related]
5. The post-BART anti-fibrinolytic dilemma?
Beattie WS; Karkouti K
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):3-5. PubMed ID: 21272775
[No Abstract] [Full Text] [Related]
6. Hemostatic drugs.
Mannucci PM
N Engl J Med; 1998 Jul; 339(4):245-53. PubMed ID: 9673304
[No Abstract] [Full Text] [Related]
7. ε-Aminocaproic acid and clinical value in cardiac anesthesia.
Raghunathan K; Connelly NR; Kanter GJ
J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):16-9. PubMed ID: 20870423
[TBL] [Abstract][Full Text] [Related]
8. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
10. [Hemostasis and antifibrinolytic therapy in major pediatric surgery].
Schindler E; Hertfelder HJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):454-61; quiz 462. PubMed ID: 23929163
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
[TBL] [Abstract][Full Text] [Related]
13. Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation.
Lerner AB
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):888-90. PubMed ID: 17138101
[No Abstract] [Full Text] [Related]
14. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
[TBL] [Abstract][Full Text] [Related]
15. Current antifibrinolytic therapy for coronary artery revascularization.
Trudell J; McMurdy N
AANA J; 2008 Apr; 76(2):121-4. PubMed ID: 18478817
[TBL] [Abstract][Full Text] [Related]
16. The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.
Henry D; Carless P; Fergusson D; Laupacis A
CMAJ; 2009 Jan; 180(2):183-93. PubMed ID: 19050037
[TBL] [Abstract][Full Text] [Related]
17. Blood conservation in liver transplantation: The role of aprotinin.
Porte RJ; Hendriks HG; Slooff MJ
J Cardiothorac Vasc Anesth; 2004 Aug; 18(4 Suppl):31S-37S. PubMed ID: 15368204
[No Abstract] [Full Text] [Related]
18. The risks associated with aprotinin use: a retrospective study of cardiac cases in Nova Scotia.
Riddell RE; Buth KJ; Sullivan JA
Can J Anaesth; 2013 Jan; 60(1):16-23. PubMed ID: 23132043
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Levi M; Cromheecke ME; de Jonge E; Prins MH; de Mol BJ; Briët E; Büller HR
Lancet; 1999 Dec; 354(9194):1940-7. PubMed ID: 10622296
[TBL] [Abstract][Full Text] [Related]
20. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
